Drug profile · INN
gabapentin enacarbil
HORIZANT
gabapentin enacarbil (HORIZANT) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — gabapentin enacarbil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gabapentin enacarbil (HORIZANT) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated calcium channel modulator
Primary target: Voltage-gated calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is gabapentin enacarbil?
gabapentin enacarbil (HORIZANT) is a voltage-gated calcium channel modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for gabapentin enacarbil?
HORIZANT is a marketed brand name for gabapentin enacarbil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gabapentin enacarbil?
gabapentin enacarbil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.